Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Aytu BioScience

    Client Virtual Booth

    AYTU BIOSCIENCE

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Aytu BioScience
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    373 Inverness Parkway, Suite 206 Englewood, CO 80112
    Telephone
    Telephone
    +1 855-298-8246
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://aytubio.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Aytu Adds Late-Stage Pediatric Onset Rare Disease Asset to Development Pipeline
    Aytu Adds Late-Stage Pediatric Onset Rare Disease Asset to Development Pipeline

    https://www.accesswire.com/639869/Aytu-BioPharma-Adds-Late-Stage-Pediatric-Onset-Rare-Disease-Asset-to-Development-Pipeline-from-Rumpus-Therapeutics

    ACCESWIRE
    13 Apr 2021
    Share Share
    Aytu BioPharma Divests U.S. Rights to Natesto(R) to Acerus Pharma
    Aytu BioPharma Divests U.S. Rights to Natesto(R) to Acerus Pharma

    https://www.accesswire.com/638540/Aytu-BioPharma-Divests-US-Rights-to-NatestoR-to-Acerus-Pharma

    ACCESSWIRE
    01 Apr 2021
    Share Share
    Aytu BioScience Announces Close of Merger with Neos Therapeutics
    Aytu BioScience Announces Close of Merger with Neos Therapeutics

    https://www.biospace.com/article/releases/aytu-bioscience-announces-close-of-merger-with-neos-therapeutics/?s=79

    BIOSPACE
    22 Mar 2021
    Share Share
    Aytu BioScience Announces Close of Merger with Neos Therapeutics
    Aytu BioScience Announces Close of Merger with Neos Therapeutics

    https://www.biospace.com/article/releases/aytu-bioscience-announces-close-of-merger-with-neos-therapeutics/?s=79

    BIOSPACE
    22 Mar 2021
    Share Share
    Aytu BioScience and Neos Therapeutics Announce Special Meetings of Stockholders
    Aytu BioScience and Neos Therapeutics Announce Special Meetings of Stockholders

    https://www.biospace.com/article/releases/aytu-bioscience-and-neos-therapeutics-announce-special-meetings-of-stockholders-related-to-proposed-merger-to-be-held-on-march-18-2021/?s=79

    BIOSPACE
    10 Feb 2021
    Share Share
    Aytu BioScience Announces Closing of $28.75 Million Bought Deal Offering
    Aytu BioScience Announces Closing of $28.75 Million Bought Deal Offering

    https://www.biospace.com/article/releases/aytu-bioscience-announces-closing-of-28-75-million-bought-deal-offering-and-full-exercise-of-underwriter-s-option-to-purchase-additional-shares/#:~:text=(NASDAQ%3AAYTU)%2C%20(,Company%2C%20which%20includes%20the%20full

    BIOSPACE
    15 Dec 2020
    Share Share
    Aytu BioScience Announces $10.0 Million Bought Deal Offering
    Aytu BioScience Announces $10.0 Million Bought Deal Offering

    https://www.accesswire.com/620494/Aytu-BioScience-Announces-100-Million-Bought-Deal-Offering

    ACCESSWIRE
    10 Dec 2020
    Share Share
    Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement,
    Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement,

    https://www.globenewswire.com/news-release/2020/12/10/2143034/0/en/Aytu-BioScience-and-Neos-Therapeutics-Announce-Definitive-Merger-Agreement-Creating-a-Combined-100M-Revenue-Specialty-Pharmaceutical-Company.html

    GLOBENEWSWIRE
    10 Dec 2020
    Share Share
    Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement
    Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement

    https://www.globenewswire.com/news-release/2020/12/10/2143034/0/en/Aytu-BioScience-and-Neos-Therapeutics-Announce-Definitive-Merger-Agreement-Creating-a-Combined-100M-Revenue-Specialty-Pharmaceutical-Company.html

    GLOBENEWSWIRE
    10 Dec 2020
    Share Share
    Aytu BioScience Announces Regulatory Approval of ZolpiMist(R) by Australian
    Aytu BioScience Announces Regulatory Approval of ZolpiMist(R) by Australian

    https://www.biospace.com/article/releases/aytu-bioscience-company-news/

    BIOSPACE
    30 Jul 2020
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search